Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

557 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Loco-regional treatment for castration-resistant prostate cancer: Is there any rationale? A critical review from the AFU-GETUG.
Beauval JB, Loriot Y, Hennequin C, Rozet F, Barthelemy P, Borchiellini D, Schlürmann Constans F, Gross E, Maillet D, Pasticier G, Pignot G, Timsit MO, Vincendeau S, Ploussard G, Sargos P. Beauval JB, et al. Among authors: hennequin c. Crit Rev Oncol Hematol. 2018 Feb;122:144-149. doi: 10.1016/j.critrevonc.2017.12.012. Epub 2017 Dec 30. Crit Rev Oncol Hematol. 2018. PMID: 29458782 Review.
Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer.
Amestoy F, Roubaud G, Antoine M, Fonteyne V, Baumann BC, Christodouleas J, Roupret M, Azria D, Zilli T, Hennequin C, Xylinas E, Sargos P; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology. Amestoy F, et al. Among authors: hennequin c. Crit Rev Oncol Hematol. 2019 Oct;142:76-85. doi: 10.1016/j.critrevonc.2019.06.010. Epub 2019 Jul 16. Crit Rev Oncol Hematol. 2019. PMID: 31377435
Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group.
Lapierre A, Hennequin C, Beneux A, Belhomme S, Benziane Ouaritini N, Biston MC, Crehange G, de Crevoisier R, Dumas JL, Fawzi M, Lisbona A, Pasquier D, Pelissier S, Graff-Cailleaud P, Pommier P, Sargos P, Simon JM, Supiot S, Tantot F, Chapet O. Lapierre A, et al. Among authors: hennequin c. Crit Rev Oncol Hematol. 2022 May;173:103661. doi: 10.1016/j.critrevonc.2022.103661. Epub 2022 Mar 25. Crit Rev Oncol Hematol. 2022. PMID: 35341986 Review.
[Active surveillance of prostate cancer].
Ploussard G, Hennequin C, Rozet F. Ploussard G, et al. Among authors: hennequin c. Cancer Radiother. 2017 Oct;21(6-7):437-441. doi: 10.1016/j.canrad.2017.07.027. Epub 2017 Aug 25. Cancer Radiother. 2017. PMID: 28847461 French.
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Sargos P, Guerif S, Latorzeff I, Hennequin C, Pommier P, Lagrange JL, Créhange G, Chapet O, de Crevoisier R, Azria D, Supiot S, Habibian M, Soulié M, Richaud P. Sargos P, et al. Among authors: hennequin c. Cancer Treat Rev. 2015 Dec;41(10):814-20. doi: 10.1016/j.ctrv.2015.10.005. Epub 2015 Oct 23. Cancer Treat Rev. 2015. PMID: 26508669 Review.
Radium 223 dichloride for prostate cancer treatment.
Deshayes E, Roumiguie M, Thibault C, Beuzeboc P, Cachin F, Hennequin C, Huglo D, Rozet F, Kassab-Chahmi D, Rebillard X, Houédé N. Deshayes E, et al. Among authors: hennequin c. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651. doi: 10.2147/DDDT.S122417. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28919714 Free PMC article. Review.
[Castration modalities in prostate cancer: Are they all equal?].
Ploussard G, Bruyère F, Culine S, de La Taille A, Hennequin C, Oudard S, Pfister C, Ravery V, Salomon L. Ploussard G, et al. Among authors: hennequin c. Prog Urol. 2016 Apr;26(5):319-28. doi: 10.1016/j.purol.2016.02.010. Epub 2016 Mar 23. Prog Urol. 2016. PMID: 27017327 Review. French.
557 results